Active

European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Switched

BE0877737261

Rechtspersoon Non-profit association 1 establishment

Quai Godefroid-Kurth 13, 4020 Liège Organisatie van congressen en beurzen

Active for

20 year, 9 months

Financials

Financial year 2025

Gross margin

€ 280,686

▲ 1055% vs 2024

Profit

Growing

€ 192,368

▲ 326% vs 2024

Debts

Low

€ 28,183

▲ 77% vs 2024

European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases from Liège, company number BE0877737261, closed financial year 2025 with a result of € 192,368 after tax. For that financial year European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases recorded a gross margin of € 280,686 and equity of € 795,470. Compared with financial year 2024, the result moved from € -84,942 to € 192,368. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 4, 2026.

What happened at European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases?

What happened at European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 192,368. Source: NBB ↗
  • Nicholas Fuggle became a director. NBB
  • Sansin Tuzun became a director. NBB
  • Nicholas Harvey became a director. NBB
  • Stefania Maggi became a director. NBB
  • Radmila Matijevic became a director. NBB
  • Nicola Veronese became a director. NBB
  • Charlotte Beaudart became a director. NBB

In short

From € 18,887 loss in 2021 to € 192,368 profit in 2025.

Best year ever: 2025, with € 192,368 profit.

A new publication or filing at European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases? We notify you, reason included.

Follow European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Jean-Yves Reginster
René Rizzoli
Nicholas Fuggle
Jean-Marc Kaufman
+10
European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Behind European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases are Jean-Yves Reginster, René Rizzoli, Nicholas Fuggle, Jean-Marc Kaufman, Olivier Bruyère and Maria-Luisa Brandi. The same people are also behind CENTRE ACADEMIQUE DE RECHERCHE ET D'EXPERIMENTATION EN SANTE and EZI Biolab.

See the full network in the app

Directors

According to the 2025 annual accounts

Jean-Yves Reginster

Chairman of the board

since 2005

René Rizzoli

Director

since 2007

Nicholas Fuggle

Director

since 2024

Jean-Marc Kaufman

Director

Also active at: CENTRE ACADEMIQUE DE RECHERCHE ET D'EXPERIMENTATION EN SANTE

since 2005

Olivier Bruyère

Managing director

since 2014

Maria-Luisa Brandi

Director

since 2009

Cyrus Cooper

Vice-chairman of the board

since 2011

Stefania Maggi

Director

since 2022

Nicholas Harvey

Director

since 2023

Radmila Matijevic

Director

since 2022

Etienne Cavalier

Director

Also active at: EZI Biolab

since 2017

Nicola Veronese

Director

since 2022

Sansin Tuzun

Director

since 2024

Charlotte Beaudart

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Quai Godefroid-Kurth 13

4020 Liège

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0877.737.261
VAT number
BE 0877.737.261
Registered office
Quai Godefroid-Kurth 13, 4020 Liège
Names & denominations
European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases · ESCEO
Enterprise type
Rechtspersoon
Legal form
Non-profit association
Legal situation
Normale toestand
Start date
6 December 2005
Peppol
Active · Active since 20 Nov 2020
Activities · NACE

Organisatie van congressen en beurzen

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Verenigingen op het vlak van ziektepreventie en gezondheidsbevordering

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Frequently asked questions

What is the enterprise number of European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases?
The enterprise number of European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases is BE0877737261.
What is the address of European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases?
The registered office of European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases is located at Quai Godefroid-Kurth 13, 4020 Liège.
When was European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases founded?
European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases was founded on 6 December 2005.
What is the main activity of European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases?
The main activity of European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases is "Organisatie van congressen en beurzen" (NACE code 82300).
Does European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases have a website?
No website is currently known for European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
How much profit did European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases make in 2025?
European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases posted a profit after taxes of € 192,368 in financial year 2025.
What is the revenue of European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases?
As a small company, European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 280,686.
Where can I find the annual accounts of European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases?
European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases?
According to the 2025 annual accounts, the directors of European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases are: Jean-Yves Reginster, René Rizzoli, Nicholas Fuggle, Jean-Marc Kaufman, Olivier Bruyère, Maria-Luisa Brandi, Cyrus Cooper, Stefania Maggi.
Who owns European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases?
Behind European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases are Jean-Yves Reginster, René Rizzoli, Nicholas Fuggle, Jean-Marc Kaufman, Olivier Bruyère and Maria-Luisa Brandi. The same people are also behind CENTRE ACADEMIQUE DE RECHERCHE ET D'EXPERIMENTATION EN SANTE and EZI Biolab.